SRSF2
Showing 1 - 22 of 22
Metastatic Solid Tumor, SF3B1 Gene Mutation, Spliceosome Mutation Trial in Baltimore (Recommendation for treatment with
Recruiting
- Metastatic Solid Tumor
- +4 more
- Recommendation for treatment with immunotherapy
-
Baltimore, MarylandJohns Hopkins University
Sep 8, 2022
SRSF2 Gene Mutation in Patients With t-MDS/AML
Completed
- Therapy Related Myelodysplastic Syndrome and Therapy Related Acute Myeloid Leukemia
- PCR and cytogenetics
-
Assiut, Egypt
- +1 more
May 17, 2020
Acute Myelogenous Leukemia, Myelodysplastic Syndrome Trial in Germany, United States (Emavusertib, Azacitidine, Venetoclax)
Active, not recruiting
- Acute Myelogenous Leukemia
- Myelodysplastic Syndrome
- Emavusertib
- +2 more
-
Tampa, Florida
- +8 more
Apr 5, 2022
Chronic Myelomonocytic Leukemia, Leukemia Trial in United States (Ruxolitinib)
Active, not recruiting
- Chronic Myelomonocytic Leukemia
- Leukemia
-
Tampa, Florida
- +4 more
Nov 11, 2022
Epigenetic Age on Clinic-biological Presentation and Prognosis
Not yet recruiting
- Myeloproliferative Neoplasm
- Assessment of the epigenetic age
-
Bordeaux, FranceCHU de Bordeaux, service Hématologie Biologique
Aug 28, 2023
Clonal Hematopoiesis of Indeterminate Potential in Venous
Active, not recruiting
- Venous Thromboembolism
-
Nîmes, FranceCHU de Nimes
Jan 24, 2022
Next Generation Sequencing in Familial Acute Myeloid Leukemia
Recruiting
- Leukemia
- Analysis with molecular biology
-
Brescia, ItalyChair of Hematology and Bone marrow Transplant Unit
Apr 21, 2022
Myocardial Infarction Trial in Pessac (Specific blood sampling)
Completed
- Myocardial Infarction
- Specific blood sampling
-
Pessac, FranceBordeaux University Hospital
Feb 21, 2022
Diagnostic Platform to Perform Centralized and Standardized
Completed
- Acute Myeloid Leukemia
- NGS techniques
-
Córdoba, Spain
- +6 more
Feb 15, 2021
MDS Trial in Innsbruck (Next Generation Sequencing, Tumorimmunological examinations - multiplex assays/quantitative polymerase
Recruiting
- Myelodysplastic Syndromes
- Next Generation Sequencing
- +5 more
-
Innsbruck, Tyrol, AustriaMedical University of Innsbruck
Apr 6, 2022
Acute Myeloid Leukemia Trial in France (Cytarabine and Idarubicin, CPX-315)
Not yet recruiting
- Acute Myeloid Leukemia
- Cytarabine and Idarubicin
- CPX-315
-
Amiens, France
- +29 more
Apr 8, 2022
GENOMED4ALL: Improving MDS Classification and Prognosis by AI
Active, not recruiting
- Myelodysplastic Syndromes
-
Milano, ItalyIstituto Clinico Humanitas
Jun 28, 2021
MDS Patients Using Sequential Peripheral Blood Samples
Recruiting
- Myelodysplastic Syndromes
-
Badalona, Barcelona, SpainJosep Carreras Leukaemia Research Institute
Mar 8, 2022
MDS Trial in Hong Kong
Recruiting
- Myelodysplastic Syndromes
-
Hong Kong, Hong KongDepartment of Medicine, the University of Hong Kong, Queen Mary
Nov 3, 2020
Lung Cancer Trial in La Tronche (Blood and respiratory fluids sampling, Biopsy, Excised tissues)
Completed
- Lung Cancer
- Blood and respiratory fluids sampling
- +2 more
-
La Tronche, FranceUniversityHospitalGrenoble
Mar 17, 2020
Myeloproliferative Tumors Trial in Taoyuan
Enrolling by invitation
- Myeloproliferative Neoplasms
-
Taoyuan, State, TaiwanChang Gung Memorial Hospital-Linkou
Aug 4, 2021
Primary Myelofibrosis, Secondary Myelofibrosis, Myeloid Malignancies Trial in Rochester (Imetelstat)
Completed
- Primary Myelofibrosis
- +2 more
-
Rochester, Minnesota(unnamed)
Aug 24, 2021
Molecular Defects in Idiopathic Cytopenia of Undetermined
Unknown status
- Myelodysplastic Syndromes
- ICUS
-
Amiens, FranceCHU Amiens
Aug 2, 2018
Aging of Hematopoietic Stem Cells - Molecular Architecture of
Completed
- Anemia
- Clonal Hematopoiesis
- targeted genome sequencing
-
Rozzano, Milano, ItalyIstituto Clinico Humanitas
Apr 19, 2019
MDS Trial in Paris (blood samples)
Completed
- Myelodysplastic Syndromes
- blood samples
-
Paris, FranceAssistance publique-Hôpitaux de Paris, Hôpital Cochin
Mar 16, 2018
Chronic Myelomonocytic Leukemia Trial in Nice
Unknown status
- Chronic Myelomonocytic Leukemia
-
Nice, FranceCHU de Nice
Mar 16, 2018
Patients With Myelodysplastic Syndrome
Completed
- Myelodysplastic Syndrome
- spliceosome
-
Seoul, Korea, Republic ofSamsung Medical Center
Feb 11, 2014